PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
05-Jun-2024 Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting Grey Wolf Therapeutics
05-Jun-2024 OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma OncoHost
05-Jun-2024 ENCOURAGING NEW DATA PRESENTED ON KITE’S YESCARTA (AXICABTAGENE CILOLECUEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA Kite, a Gilead Company
05-Jun-2024 Brandon Capital Announces Sixth Fund with A$270 million (US$180 million) Initial Close to Drive Life Science Innovation Brandon Capital
05-Jun-2024 invoX Pharma Presents Positive Clinical Data from Phase 1 Study of FS222 in Patients with Advanced Solid Tumours at the 2024 American Society of Clinical Oncology Annual Meeting invoX Pharma
05-Jun-2024 Shionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats Shionogi & Co., Ltd
05-Jun-2024 New WISH report to focus on the ethical management of AI in healthcare WORLD INNOVATION SUMMIT FOR HEALTH
05-Jun-2024 Scottish healthcare innovators urged to apply to NHS Clinical Entrepreneur Programme by InnoScot Health InnoScot Health
04-Jun-2024 Discover Cutting-Edge Medical Innovations and Global Healthcare Advancements at the Florida International Medical Expo (FIME) Florida International Medical Expo (FIME)
04-Jun-2024 Our children deserve better – HOYA Vision Care calls for urgent action to address childhood myopia Hoya Vision Care
03-Jun-2024 ENCOURAGING NEW DATA PRESENTED ON KITE’S YESCARTA (AXICABTAGENE CILOLECUEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA Kite, a Gilead Company
03-Jun-2024 Lundbeck presents innovative first in human trial design of Lu AG13909 for potential treatment of congenital adrenal hyperplasia H. Lundbeck A/S
03-Jun-2024 TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team TMC Pharma Services Ltd
03-Jun-2024 Qlucore starts project after receiving prestigious EU grant to advance personalized cancer treatment Qlucore
03-Jun-2024 STORM Therapeutics Presented Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 STORM Therapeutics
03-Jun-2024 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine HUTCHMED
03-Jun-2024 Leading Biopharmaceutical Companies Unite to Advance SCE with Domino Domino Data Lab
31-May-2024 AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis AbbVie
30-May-2024 Result of Placing and Subscription Cambridge Cognition Holdings plc
30-May-2024 New boost for TechBio companies seeking investment The UK Bioindustry Association (BIA)